Adams Diversified Equity Fund’s AMAG Pharmaceuticals AMAG Stock Holding History

Adams Diversified Equity Fund’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,500	Closed	-$95K	–	221
2019 Q2	$95K	Sell	9,500 -2,300	-19%	-$24.8K	0.01%	210
2019 Q1	$152K	Sell	11,800 -12,400	-51%	-$185K	0.01%	216
2018 Q4	$368K	Buy	24,200 +5,700	+31%	+$109K	0.02%	200
2018 Q3	$370K	Sell	18,500 -1,300	-7%	-$29.6K	0.02%	208
2018 Q2	$386K	Sell	19,800 -1,700	-8%	-$37.6K	0.02%	210
2018 Q1	$433K	Hold	21,500	–	–	0.02%	208
2017 Q4	$285K	Sell	21,500 -6,200	-22%	-$93.5K	0.02%	204
2017 Q3	$511K	Sell	27,700 -1,000	-3%	-$18.6K	0.03%	211
2017 Q2	$528K	Sell	28,700 -5,500	-16%	-$109K	0.03%	206
2017 Q1	$771K	Buy	34,200 +11,500	+51%	+$275K	0.04%	197
2016 Q4	$790K	Buy	+22,700	New	+$678K	0.05%	190

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Adams Diversified Equity Fund's AMAG Position: Q3 2019 in Review

Adams Diversified Equity Fund sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 9,500 shares — an estimated $95K sold.

Adams Diversified Equity Fund first reported a position in AMAG in Q4 2016 and held it in 11 quarters. The position peaked at $790K in Q4 2016. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

Adams Diversified Equity Fund reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Adams Diversified Equity Fund sold 9,500 AMAG Pharmaceuticals shares in Q3 2019, an estimated $95K.
Adams Diversified Equity Fund first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 11 quarters.
Adams Diversified Equity Fund's AMAG Pharmaceuticals position peaked at $790K in Q4 2016.
156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2019, filed 28 Oct 2019.